Vai al contenuto principale della pagina

Radiolabeled Compounds for Diagnosis and Treatment of Cancer



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Autore: Kumar Krishan Visualizza persona
Titolo: Radiolabeled Compounds for Diagnosis and Treatment of Cancer Visualizza cluster
Pubblicazione: Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica: 1 electronic resource (262 p.)
Soggetto topico: Research & information: general
Chemistry
Soggetto non controllato: positron emission tomography (PET)
pyrazoles
fluorine-18
radionuclides
PET probes
imaging pharmaceuticals
hypopharyngeal cancer
188Re-liposome
repeated therapy
NGS
microRNA
aprepitant
radiopharmaceuticals
neurokinin 1 receptor antagonist
radionuclide chelators
kidney uptake
cleavable linkers
neutral endopeptidase (NEP)
renal brush border enzymes
prostate-specific membrane antigen (PSMA)
cancer imaging and therapy
somatostatin analogs
radiolabeling
radionuclide therapy
imaging
adrenergic receptor
positron emission tomography
radiotracer
cholecystokinin-2 receptor
minigastrin
molecular imaging
targeted radiotherapy
lutetium-177
EpCAM
radionuclide
SPECT
iodine
PIB
breast
cancer
PET
target-specific biomolecules
immunoPET imaging pharmaceuticals
production processes
124I-labeled monoclonal antibodies
radiotracers
AAZTA
scandium-44
FAP
SA
DPP
PREP
radioiodine labeling
radioiodination
biomolecules
peptides
proteins
monoclonal antibodies
123,124,125,131I-labeled molecules and biomolecules
Persona (resp. second.): KumarKrishan
Sommario/riassunto: Radiopharmaceuticals are used in the diagnosis and treatment of various diseases, especially cancer. In general, radiopharmaceuticals are either salts of radionuclides or radionuclides bound to biologically active molecules, drugs, or cells. Tremendous progress has been made in discovering, developing, and commercializing numerous radiopharmaceuticals for the imaging and therapy of cancer. Significant research is ongoing in academia and the pharmaceutical industry to develop more novel radiolabeled compounds as potential radiopharmaceuticals for unmet needs. This Special Issue aims to focus on all aspects of the design, characterization, evaluation, and development of novel radiolabeled compounds for the diagnosis and treatment of cancer and the application of new radiochemistry and methodologies for the development of novel radiolabeled compounds. Outstanding contributions presented in this Special Issue will significantly add to the field of radiopharmaceuticals.
Titolo autorizzato: Radiolabeled Compounds for Diagnosis and Treatment of Cancer  Visualizza cluster
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910557512703321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui